A small study supports the mounting evidence that targeted immunotherapy can help improve cognitive ability in people with schizophrenia.
Sulforaphane, a compound derived from broccoli sprouts, may be a useful new treatment for those suffering from schizophrenia. In a recent set of animal and human studies, researchers characterized novel chemical imbalances in the brain related to glutamate. Levels of glutamate, they discovered, can be altered by administering sulforaphane.
The retrosplenial cortex plays a vital role in value-based decision making.
Analyzing the results of 15 different studies involving over 300 subjects, researchers discovered a single dose of THC could induce psychiatric symptoms in people with no history of psychosis.
Researchers have identified a neural system involved in making decisions based on preference.
A new investigation into interneuron development sheds light on how disorders associated with neurodevelopment, such as autism and schizophrenia may occur.
Using transcranial magnetic stimulation, researchers have successfully restored network function between the prefrontal cortex and cerebellum, helping to improve symptoms in those with treatment resistant schizophrenia.